immune response

Sensory neurons grow into injured tissues and modulate the immune system to promote healing.

Ever since its discovery in the 1900s, the production of a potent vaccine adjuvant relied on the Chilean soapbark tree. Now, yeast can make the molecule.

A salivary protein in mosquitos can suppress host immune activity and aid viral transmission.

Vaccination through the eyes stimulated a protective response in the brains of mice, revealing an immunological link between these two organs.

Timely modulation of a common signaling pathway can preserve influenza memory in lung T cells.

Immune receptor repertoire profiling is an important analytic tool for disease research in many areas, including cancer, cell and organ transplantation, autoimmunity, and infectious disease. 

Scientists present the latest research on immune cell responses to cancer, the role of epigenetics in cancer, and molecular imaging of the tumor microenvironment.

Researchers uncover innovative natural approaches to fine-tune immunity from vaccination.

Immune cells and pain neurons form complex partnerships to protect our bodies from pathogens, new research reveals.

The oil’s omega-3 fatty acids accumulate in the mice’s skin, triggering an immune response that causes hair loss.

How single-cell secretomic analysis revealed the role of TEMRA CD8⁺ T cells in kidney transplant rejection.

A high-fat diet induced changes to the animals’ vaginal microbiomes that boosted survival after exposure to the virus.

Researchers build better vaccines thanks to innovative technology.

In people with the genetic condition, inflammation can cause a mild infection to snowball out of control, a study finds.

Immune cells deliver packages of telomeres to T cells, helping them retain their virus-fighting function over time, research suggests.

What triggers type 1 diabetes has been difficult to prove, but a bacterium that produces an insulin-like peptide can give mice type 1 diabetes, and infection with the microbe seems to predict the onset of the disease in humans.

The newly authorized intradermal vaccination only requires one-fifth of the usual vaccine dose. This will help stretch out the limited vaccine supply, experts say, but only if healthcare personnel receive sufficient training.

The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.

Mat Robinson and Mark Tangney discuss how enhancing the efficacy of immune checkpoint inhibitors improves patient outcomes.